Literature DB >> 20621392

Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit.

S S S Levy1, M J G Mello, F A R Gusmão-Filho, J B Correia.   

Abstract

A prospective cohort study was performed in order to study the incidence and risk factors for bacterial colonisation with extended-spectrum producing beta-lactamase (ESBL) Klebsiella spp. in children. The study took place in a paediatric intensive care unit (PICU) in Recife, Brazil over a five-month period in 2008. Rectal swabs were collected during the first 24h of admission and on the 2nd, 5th, 7th and 14th days of PICU stay. ESBL-producing strains of Klebsiella spp. were detected by Kirby-Bauer disc diffusion and confirmed by double disc synergy testing. A total of 186 children were enrolled with a median age of three years. The overall colonisation rate with ESBL-producing Klebsiella spp. was 14%, but 13 (7%) children were already colonised upon admission. The incidence density of colonisation during PICU admission was 14.2 per 1000 patient-days. On multivariable analysis, the use of third generation cephalosporins (P=0.008) was a risk factor for colonisation. Survival analysis revealed an increase in the accumulated risk of colonisation with an increase in length of stay in the PICU. The present study provides baseline information to guide improved practices in similar settings and direct future studies in relation to the magnitude of cross-infection and effectiveness of infection control interventions. Copyright 2010 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621392     DOI: 10.1016/j.jhin.2010.03.008

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Raman spectroscopic analysis of the clonal and horizontal spread of CTX-M-15-producing Klebsiella pneumoniae in a neonatal intensive care unit.

Authors:  K Guyot; V Biran; C Doit; D Moissenet; T Guillard; L Brasme; C Courroux; K Maquelin; W van Leeuwen; H Vuthien; Y Aujard; C De Champs; E Bingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-27       Impact factor: 3.267

2.  Suspicion of respiratory tract infection with multidrug-resistant Enterobacteriaceae: epidemiology and risk factors from a Paediatric Intensive Care Unit.

Authors:  Hanna Renk; Lenja Stoll; Felix Neunhoeffer; Florian Hölzl; Matthias Kumpf; Michael Hofbeck; Dominik Hartl
Journal:  BMC Infect Dis       Date:  2017-02-21       Impact factor: 3.090

3.  Intense intestinal carriage and subsequent acquisition of multidrug-resistant enterobacteria in neonatal intensive care unit in Morocco.

Authors:  Btissam Arhoune; Samira El Fakir; Sara Himri; Kaoutar Moutaouakkil; Salma El Hassouni; Moussa Benboubker; Fouzia Hmami; Bouchra Oumokhtar
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

4.  Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan.

Authors:  Manzoor Ahmad; Mukhtiar Hassan; Anwar Khalid; Imran Tariq; Muhammad Hassham Hassan Bin Asad; Abdul Samad; Qaisar Mahmood; Ghulam Murtaza
Journal:  Biomed Res Int       Date:  2016-06-05       Impact factor: 3.411

Review 5.  Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America.

Authors:  Manuel Guzmán-Blanco; Jaime A Labarca; Maria Virginia Villegas; Eduardo Gotuzzo
Journal:  Braz J Infect Dis       Date:  2014-01-03       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.